Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05573113 · ClinicalTrials.gov registry record · NA
Comparative Effectiveness Trial for Diagnosis of Necrotizing Enterocolitis
A NA study, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- NA
- Development phase
- 169
- Enrollment target
NCT05573113: Completed NA study, sponsored by Children's Mercy Hospital Kansas City.
NCT05573113 is a NA study that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 169 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05573113, a NA study, has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- NA
- Development phase
- 169 participants
- Enrollment target
Study Summary
The overall objective of our study is to determine the clinical usefulness of BUS for NEC evaluation in diverse NICU settings.
Primary Outcome
Number of days for infants to tolerate at least 120 mL/kg/day of enteral feeds
Interventions
- DIAGNOSTIC_TEST Bowel Ultrasound
- DIAGNOSTIC_TEST Abdominal radiograph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 169 participants |
| Start Date | 2022-11-01 |
| Est. Completion | 2025-09-18 |
| Phase | NA |
What the finished NCT05573113 record still lists
NCT05573113 is an interventional study that assigns participants to a tested intervention. The registered 169 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 2 interventions - of which Bowel Ultrasound is the first listed.
NCT05573113 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05573113 about?
NCT05573113 is a clinical study titled "Comparative Effectiveness Trial for Diagnosis of Necrotizing Enterocolitis". The overall objective of our study is to determine the clinical usefulness of BUS for NEC evaluation in diverse NICU settings.
What is the current status of trial NCT05573113?
This trial is currently completed. It is a NA study. The enrollment target is 169 participants. The study started on 2022-11-01. Estimated completion is 2025-09-18.
What interventions are being tested in trial NCT05573113?
The interventions under investigation include: Bowel Ultrasound (DIAGNOSTIC_TEST), Abdominal radiograph (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05573113?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05573113's enrollment target sits among peer trials
169 619th of 2000 higher than 1,382 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06191484 · 169 participants · NA
Risk and Resilience to Suicide Following Late-Life Spousal Bereavement
- NCT02016430 · 170 participants · NA
Gut Flora Metabolite Reduction After Dietary Intervention (GRADY)
- NCT02621021 · 170 participants · Phase 2
A Phase 2 Trial for Metastatic Melanoma Using Adoptive Cell Therapy With Tumor Infiltrating Lymphocytes Plus IL-2 Either Alone or Following the Administration of Pembrolizumab
- NCT04094701 · 170 participants · NA
Hip Arthroscopy Postoperative Opioid Demands
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI